WELL:PA:PA-HAN-GINS Indxx Healthcare Megatrend Equal Weight UCITS ETF - Accumulating EUR (EUR)

ETF | Others |

Last Closing

USD 6.4953

Change

+0.06 (+0.98)%

Market Cap

N/A

Volume

152.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-24 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

+0.20 (+0.44%)

USD 61.38B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

+4.40 (+0.77%)

USD 13.43B
WRD:PA HSBC MSCI World UCITS ETF

+0.27 (+0.76%)

USD 11.05B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

+3.57 (+0.88%)

USD 9.62B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

-0.25 (-0.11%)

USD 8.55B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

+4.50 (+0.89%)

USD 8.53B
HHH:PA HSBC S&P 500 UCITS ETF

+0.46 (+0.79%)

USD 7.68B
WLD:PA Lyxor UCITS MSCI World D-EUR

+3.17 (+0.89%)

USD 7.63B
LCWD:PA Multi Units Luxembourg - Lyxor..

+0.17 (+0.88%)

USD 6.83B
S500:PA Amundi S&P 500 ESG UCITS ETF A..

+1.58 (+0.97%)

USD 5.48B

ETFs Containing WELL:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -1.86% 10% F 41% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -1.86% 9% A- 39% F
Trailing 12 Months  
Capital Gain -2.12% 10% F 40% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -2.12% 9% A- 39% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -0.55% 15% F 31% F
Dividend Return -0.55% 15% F 30% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 5.94% 84% B 98% N/A
Risk Adjusted Return -9.19% 15% F 28% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.